ElastiFlow and Rohde & Schwarz Collaborate To Deliver Unmatched Network Traffic Insights
21.5.2025 16:00:00 CEST | Business Wire | Press Release
ElastiFlow, a pioneer in the observability space, today announced a strategic partnership with Rohde & Schwarz, one of the world’s leading manufacturers of test and measurement, secure communications, monitoring and network testing, and broadcasting equipment. This collaboration aims to improve network visibility and data enrichment capabilities for enterprises worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250521910528/en/
Network flow data, in the form of IPFIX records, is essential for understanding network traffic, detecting anomalies, and ensuring optimized performance and robust security. The new alliance leverages ElastiFlow to enrich IPFIX records from Rohde & Schwarz solutions, transforming raw data into actionable insights. This enables rapid, real-time detection of network events, security threats, and application performance issues.
The collaboration allows for deep packet inspection (DPI) technology to enhance IPFIX-based systems by providing granular, real-time analytics on application usage and user behavior. The partnership increases operational efficiency by eliminating redundancies, optimizing reporting streams, and driving deeper visibility into network performance, allowing network teams to make fast, data-driven decisions.
“We are excited to partner with ElastiFlow to bring unparalleled network traffic insights to enterprises worldwide. By combining our advanced deep packet inspection capabilities with ElastiFlow’s innovative network flow data technology, we can provide customers with a more comprehensive understanding of their network activity. This partnership underscores our commitment to delivering cutting-edge solutions that address the evolving needs of modern network visibility, and we look forward to working together to drive innovation and excellence in the industry.” Dr. Ing. Martin Mieth, Director Network Analysis for ipoque – A Rohde & Schwarz Company.
“This partnership with Rohde & Schwarz underscores ElastiFlow’s ability to integrate seamlessly with industry-leading technologies to deliver powerful, real-time network insights. Combining our enriched flow data with their deep packet inspection and network monitoring expertise enables enterprises to eliminate blind spots, optimize performance, and strengthen security. This demonstrates the trust in ElastiFlow’s solutions and our commitment to providing scalable, high-value integrations that enhance the broader network observability ecosystem.”
— Rob Cowart, Founder & CEO, ElastiFlow
Organizations or OEMs looking to enhance their data integration with innovative DPI and IPFIX technologies can visit our partner page to learn more.
About Rohde & Schwarz
Rohde & Schwarz is striving for a safer and connected world with its Test & Measurement, Technology Systems and Networks & Cybersecurity divisions. For over 90 years, the global technology group has pushed technical boundaries with developments in cutting-edge technologies. The company’s leading-edge products and solutions empower industrial, regulatory, and government customers to attain technological and digital sovereignty. The privately owned Munich-based company can act independently, long-term, and sustainably. Rohde & Schwarz generated net revenue of 2.93 billion euros in the 2023-2024 fiscal year (July to June). As of June 30, 2024, Rohde & Schwarz had more than 14,400 employees worldwide.
Additional information can be found at Rohde & Schwarz (www.rohde-schwarz.com), or connect with Rohde & Schwarz on Twitter or LinkedIn.
More information about the product can be found at ipoque – A Rohde & Schwarz Company
About ElastiFlow
ElastiFlow ensures connectivity across complex networks by providing real-time, contextualized observability for all connected services and applications. By eliminating data silos and connectivity blind spots, we enable seamless, proactive collaboration across NetOps, SecOps, and DevOps – accelerating detection and response, optimizing resources, streamlining service deployments, and delivering exceptional user experiences. Additional information can be found at ElastiFlow Inc. (www.elastiflow.com), or connect with ElastiFlow on Twitter and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250521910528/en/
Contacts
For more information, please contact:
PR@elastiflow.com
1-303-898-3004
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom